ASMB exercises U.S. profit-share option with Gilead
Assembly Biosciences (ASMB) exercised a U.S. profit-share option with Gilead for its HSV helicase-primase inhibitor program.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.